Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
IVF Hartmann Holding AG is a Switzerland-based holding company specializing in the production and distribution of medical consumer goods, primarily in Switzerland and internationally. Founded in 1870 and headquartered in Neuhausen am Rheinfall, it offers a wide array of products including bandages, wound care items, accident prevention equipment, hygiene products, incontinence management solutions, disinfection supplies, and housekeeping tools like liquid soap dispensers. The company operates through key segments such as infection management, wound care, incontinence management, and other group activities, with the majority of sales generated domestically. Employing approximately 300 people, IVF Hartmann Holding AG serves hospitals, doctors, surgery centers, care facilities, pharmacies, wholesalers, and corporate medical centers, while also providing consulting services on product usage. Its production encompasses research and development, distribution logistics, and specialized segments like coating, medical products, elastic bandages, and hygiene items. As a significant player in the medical equipment, supplies, and distribution sector, it supports essential healthcare needs with high-quality, reliable offerings.
12.91% operating margin is respectable but not wide. ROIC at 11.51%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue growth slowed to 1.8%, essentially flat. Margins also contracted 1.5pp. This is a business that needs a catalyst.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
CHF 162M
▲ +1.8% YoY
Net Income (TTM)
CHF 18M
▼ -9.9% YoY
Op. Margin
12.91%
▼ -1.5pp YoY
ROIC
11.51%
▼ -1.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 17M
▼ -1.9% YoY
Op. Cash Flow (TTM)
CHF 21M
▲ +4.8% YoY
Net Debt
-CHF 110M
Net Cash Position
Cash & Equiv.
CHF 112M
3Y CAGR: +2.4%
3Y CAGR: +5.2%
Continue Research